These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


277 related items for PubMed ID: 8061842

  • 1. 24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison.
    Vreugdenhil G, van Montfrans GA, Jacobs MC, de Bruijn JH, Veerman DP, van Es PN, Mellein B, Guitard C, Thien T, de Leeuw PW.
    Blood Press Suppl; 1994; 2():23-30. PubMed ID: 8061842
    [Abstract] [Full Text] [Related]

  • 2. Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily.
    Hayduk K, Schardt F, Sierakowski B, Weidinger G, Welzel D.
    Blood Press Suppl; 1994; 2():41-6. PubMed ID: 8061845
    [Abstract] [Full Text] [Related]

  • 3. Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension.
    Guitard C, Alvisi V, Maibach E, Franck J, Cocco G, Boxho G, Mellein B, Waite R.
    Blood Press Suppl; 1994; 2():81-7. PubMed ID: 8061853
    [Abstract] [Full Text] [Related]

  • 4. A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. UK Study Group of Spirapril in Hypertension.
    Fairhurst GJ.
    Blood Press Suppl; 1994; 2():77-80. PubMed ID: 8061852
    [Abstract] [Full Text] [Related]

  • 5. Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension.
    Guitard C, Sassano P, Tzincoca C, Duchiez J, Safar ME.
    Blood Press Suppl; 1994; 2():61-8. PubMed ID: 8061848
    [Abstract] [Full Text] [Related]

  • 6. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH, Man in 't Veld AJ, Admiraal PJ, Ritsema van Eck HJ, Boomsma F, Derkx FH, Schalekamp MA.
    J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [Abstract] [Full Text] [Related]

  • 8. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
    Magliano MF, Amodeo C, Mion Júnior D, Francischetti E, Lima Júnior E, Nobre F, Chaves H, Ribeiro JM, Spritzer N, Jardim PC.
    Arq Bras Cardiol; 1993 Nov; 61(5):311-8. PubMed ID: 8147731
    [Abstract] [Full Text] [Related]

  • 9. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 10. [Duration of action of trandolapril in mild to moderate hypertensive patients evaluated by ambulatory measurement of blood pressure].
    Kownator S, Dutrey-Dupagne C, Vaur L, Chevrier J, Diesel J, D'Hotel R, Schaaf R, Courvoisier A, Breton C.
    Therapie; 1994 Feb; 49(2):89-93. PubMed ID: 7817355
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 12. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P, Dallocchio M, Gourgon R.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.
    Johnson AG, Pearce GL, Danoff TM.
    J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907
    [Abstract] [Full Text] [Related]

  • 14. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A, Boivin JM, Bernaud C, Fay R, Zannad F, CIC General Practitioners Investigators' Group.
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacy of perindopril and enalapril once daily using 24-hour ambulatory blood pressure monitoring.
    Yusoff K, Razak TA, Yusof N, Rafee NM.
    Int J Clin Pract; 1999 Jun; 53(4):277-80. PubMed ID: 10563072
    [Abstract] [Full Text] [Related]

  • 16. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A, Dunne B, Glazer N, Kostis JB, Miller WE, Rector DJ, Tresznewsky ON.
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [Abstract] [Full Text] [Related]

  • 17. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B, Ghobrial H, Vaur L, Poncelet P, Asmar R, Herpin D, Mallion JM.
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [Abstract] [Full Text] [Related]

  • 18. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T, Lehtonen A.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.